Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADH1A | P07327 | 6/20 | 0.39 |
| ▸ | ADH1C | P00326 | 4/20 | 0.39 |
| ▸ | ADH4 | P08319 | 1/20 | 0.35 |
| ▸ | PHGDH | O43175 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL64029 | 0.95 | ADH1A (0.42) | ADH1AADH1CADH4PHGDH | |
| SCHEMBL99438 | 0.91 | ADH1A (0.43) | ADH1AADH1CADH4PHGDH | |
| SCHEMBL97243 | 0.91 | ADH1A (0.43) | ADH1AADH1CADH4PHGDH | |
| SCHEMBL19591971 | 0.91 | ADH1A (0.43) | ADH1AADH1CADH4PHGDH | |
| SCHEMBL11277355 | 0.91 | ADH1A (0.43) | ADH1AADH1CADH4PHGDH | |
| SCHEMBL19592023 | 0.91 | ADH1A (0.43) | ADH1AADH1CADH4PHGDH | |
| SCHEMBL19997015 | 0.91 | ADH1A (0.43) | ADH1AADH1CADH4PHGDH | |
| SCHEMBL65968 | 0.91 | ADH1A (0.43) | ADH1AADH1CADH4PHGDH | |
| SCHEMBL21289754 | 0.91 | ADH1A (0.43) | ADH1AADH1CADH4PHGDH | |
| SCHEMBL19591972 | 0.91 | ADH1A (0.43) | ADH1AADH1CADH4PHGDH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110627832-A | Preparation method for synthesizing tenofovir alafenamide by oxidation method | 江西农业大学 | 2019-12-31 | — | — | CN | claimed |
| CN-110551153-A | Preparation method for synthesizing tenofovir alafenamide by three-step method | UNIV JIANGXI AGRICULTURAL | 2019-12-10 | — | — | CN | claimed |
| CN-110627832-A | Preparation method for synthesizing tenofovir alafenamide by oxidation method | 江西农业大学 | 2019-12-31 | — | — | CN | disclosed |
| CN-110590844-A | Preparation method for synthesizing tenofovir alafenamide by two-step method | 江西农业大学 | 2019-12-20 | — | — | CN | disclosed |
| CN-110551153-A | Preparation method for synthesizing tenofovir alafenamide by three-step method | UNIV JIANGXI AGRICULTURAL | 2019-12-10 | — | — | CN | disclosed |
| EP-2076558-B1 | COMPOSITION COMPRISING NEOPENTASILANE AND METHOD OF PREPARING SAME | DOW CORNING (US) | 2018-04-18 | — | — | EP | disclosed |
| EP-2067770-B1 | PROCESS FOR PRODUCTION OF SULFONIC ACID ESTER | WAKO PURE CHEM IND LTD (JP) | 2017-04-12 | — | — | EP | disclosed |
| EP-2602856-B1 | NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS ELECTROLYTE BATTERY USING SAME | WAKO PURE CHEM IND LTD (JP) | 2017-02-22 | — | — | EP | disclosed |
| US-9257720-B2 | Nonaqueous electrolyte solution and nonaqueous electrolyte battery using same | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2016-02-09 | — | — | US | disclosed |
| US-9206106-B2 | Production method of carbonyl compound | KUREHA CORPORATION (JP) | 2015-12-08 | — | — | US | disclosed |
| US-9190695-B2 | Nonaqueous electrolyte solution, method for producing same, and nonaqueous electrolyte battery using the electrolyte solution | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2015-11-17 | — | — | US | disclosed |
| US-20100324314-A1 | PROCESS FOR PRODUCING ESTER COMPOUND | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2010-12-23 | — | — | US | disclosed |
| EP-2248821-A1 | SUBSTRATE FOR ASSAYING -GLUCAN AND/OR ENDOTOXIN AND ASSAY METHOD | Wako Pure Chemical Industries, Ltd. (JP) | 2010-11-10 | — | — | EP | disclosed |
| US-20100176338-A1 | Composition Comprising Neopentasilane And Method Of Preparing Same | NATA SEMICONDUCTOR MATERIALS CO., LTD. (CN) | 2010-07-15 | — | — | US | disclosed |
| US-20100041916-A1 | PROCESS FOR PRODUCTION OF SULFONIC ACID ESTER | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2010-02-18 | — | — | US | disclosed |
| EP-2076558-A1 | COMPOSITION COMPRISING NEOPENTASILANE AND METHOD OF PREPARING SAME | Dow Corning Corporation (US) | 2009-07-08 | — | — | EP | disclosed |
| EP-2067770-A1 | PROCESS FOR PRODUCTION OF SULFONIC ACID ESTER | Wako Pure Chemical Industries, Ltd. (JP) | 2009-06-10 | — | — | EP | disclosed |
| US-20090069546-A1 | PYRAZOLE-BASED CYANINE DYE | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2009-03-12 | — | — | US | disclosed |
| EP-2006289-A1 | PYRAZOLE-TYPE CYANINE DYE | Wako Pure Chemical Industries, Ltd. (JP) | 2008-12-24 | — | — | EP | disclosed |
| WO-2008051328-A1 | COMPOSITION COMPRISING NEOPENTASILANE AND METHOD OF PREPARING SAME | DOW CORNING CORPORATION (US) | 2008-05-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100041916-A1 | PROCESS FOR PRODUCTION OF SULFONIC ACID ESTER | SULT1A1, SULT2A1, STS | ADH1A 308/4885ADH1C 341/4885ADH4 245/4885 |
| US-20090069546-A1 | PYRAZOLE-BASED CYANINE DYE | CBR3, CYB5R3, TST | ADH1A 2847/4885ADH1C 3114/4885ADH4 654/4885 |
| US-20100324314-A1 | PROCESS FOR PRODUCING ESTER COMPOUND | ADH1C, ADH5, ADH1A | ADH1A 3/4885ADH1C 1/4885ADH4 44/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.